MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 137 filers reported holding MERSANA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,324 | -59.6% | 31,751 | +4.7% | 0.00% | – |
Q2 2023 | $99,816 | -4.6% | 30,339 | +19.2% | 0.00% | – |
Q1 2023 | $104,649 | -18.3% | 25,462 | +16.4% | 0.00% | – |
Q4 2022 | $128,141 | +0.1% | 21,867 | +15.6% | 0.00% | – |
Q3 2022 | $128,000 | +100.0% | 18,920 | +35.7% | 0.00% | – |
Q2 2022 | $64,000 | +42.2% | 13,938 | +24.8% | 0.00% | – |
Q1 2022 | $45,000 | -30.8% | 11,169 | +6.3% | 0.00% | – |
Q4 2021 | $65,000 | -73.5% | 10,511 | -59.6% | 0.00% | – |
Q3 2021 | $245,000 | -30.6% | 26,013 | -0.1% | 0.00% | – |
Q2 2021 | $353,000 | -73.1% | 26,040 | -67.9% | 0.00% | -100.0% |
Q1 2021 | $1,313,000 | -36.6% | 81,156 | +4.3% | 0.00% | -50.0% |
Q4 2020 | $2,070,000 | – | 77,783 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |